Jason Amello

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Zoran Zdraveski, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jason Amello

Form 4 holding Chief Financial Officer

Candel Therapeutics, Inc.

Security class
Common Stock
Shares / value
202,009
Estimated value
$181,808
Report date
28 Nov 2023
Price
$0.9000
Ownership
Direct
Form 4 holding Chief Financial Officer

Candel Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
90,000
Estimated value
Report date
28 Apr 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Acer Therapeutics Inc.

Security class
Stock Option (right to buy)
Shares / value
20,000
Estimated value
Report date
14 Mar 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Jason Amello

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .